Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, how many prescriptions for pancreatic enzyme replacement therapy were dispensed by Norfolk and Waveney (a) integrated care board and (b) clinical commissioning group in each year between 2019 and 2024.

The Prescription Cost Analysis (PCA) provided by the NHS Business Services Authority gives the total number of prescription items of each medicine dispensed in the community in England. The following data relates to prescriptions for products that fall within the definition as set out in Paragraph 010904, related to pancreatin, in the British National Formulary.

The following table shows the total number of National Health Service prescription items that were dispensed in the Norfolk and Waveney Integrated Care Board, regardless of where prescribed, from January 2019 to November 2024

Note: data for 2024 is from January to November.

The Clinical Commissioning Group (CCG) relates to the prescribing organisation, so the following statistics are consistent with the English Prescribing datasets rather than the dispensing organisation shown in PCA.

The following table shows the total number of NHS prescription items that were prescribed by cost centres linked to the Sub Integrated Care Board Location (SICBL), or prior to 2020 the CCG area of Norfolk and Waveney, from January 2019 to November 2024:

Note: data for 2024 is from January to November.

Historical data has been re-presented using the latest NHS organisation structure. These two tables are not directly comparable as the data available for integrated care boards relates to dispensing, whereas the data available at the SICBL or CCG level relates to items prescribed.